Hospira, Inc., Issues A Voluntary Nationwide Recall for one lot of BACTERIOSTATIC WATER for Injection, USP, due to a Potential Lack of Sterility Assurance Hospira, Inc., a Pfizer company, is voluntarily recalling BACTERIOSTATIC WATER for Injection, USP, 30 mL, multi-dose vial, lot W20308, to the Hospital/Retail level
The solubility score based on the Protein-Sol web server was computed to be 0.796, 0.801, and 0.821 (cutoff: 0.45) for nGLP1-DARPin, mGLP1-DARPin-1, and mGLP1-DARPin-2, respectively
Addy-Orduna et al
Think of it as putting bacteria into a state of suspended animation
But we do not yet have a randomized controlled trial specifically testing L
While no formal clinical trials exist for this specific combination, analyzing their individual actions provides a strong basis for speculative synergy